These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27476771)

  • 1. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions.
    Phadke C; Sharma J; Sharma K; Bansal AK
    Mol Pharm; 2019 Oct; 16(10):4139-4148. PubMed ID: 31454247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
    Grzybowska K; Chmiel K; Knapik-Kowalczuk J; Grzybowski A; Jurkiewicz K; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1154-1168. PubMed ID: 28241116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
    J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H; Taylor LS
    Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical stability of l-ascorbic acid amorphous solid dispersions in different polymers: A study of polymer crystallization inhibitor properties.
    Christina B; Taylor LS; Mauer LJ
    Food Res Int; 2015 Oct; 76(Pt 3):867-877. PubMed ID: 28455073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colyophilized Sugar-Polymer Dispersions for Enhanced Processing and Storage Stability.
    Giannachi C; Allen E; Egan G; Vucen S; Crean A
    Mol Pharm; 2024 Jun; 21(6):3017-3026. PubMed ID: 38758116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Taylor LS
    Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
    Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
    J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
    Knopp MM; Nguyen JH; Becker C; Francke NM; Jørgensen EB; Holm P; Holm R; Mu H; Rades T; Langguth P
    Eur J Pharm Biopharm; 2016 Apr; 101():145-51. PubMed ID: 26899127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.